Wednesday, September 24, 2014

Batten Disease Global Clinical Trials Industry Review, H1, 2014

The Report “Batten Disease Global Clinical Trials Review, H1, 2014″ is now available at lifescienceindustryresearch.com Contact sales@lifescienceindustryresearch.com  with Report name in subject line and your contact details to purchase this report or get your questions answered.

Researcher’s clinical trial report, “Batten Disease Global Clinical Trials Review, H1, 2014″ provides data on the Batten Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Batten Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Batten Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Researcher’s team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Introduction 4
Batten Disease 4
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Europe 8
Top Countries Contributing to Clinical Trials in North America 9
Clinical Trials by G7 Countries: Proportion of Batten Disease to Central Nervous System Clinical Trials 10
Clinical Trials by Phase in G7 Countries 11
Clinical Trials in G7 Countries by Trial Status 12
Clinical Trials by Phase 13
In Progress Trials by Phase 14
Clinical Trials by Trial Status 15
Unaccomplished Trials of Batten Disease 16
Subjects Recruited Over a Period of Time 17
Clinical Trials by Sponsor Type 18
Prominent Sponsors 19
Top Companies Participating in Batten Disease Therapeutics Clinical Trials 20
Prominent Drugs 21
Clinical Trial Profiles 22
Clinical Trial Overview of Top Companies 22
Stem Cell Sciences UK Ltd 22
Clinical Trial Overview of Stem Cell Sciences UK Ltd 22
BioMarin Pharmaceutical Inc. 23
Clinical Trial Overview of BioMarin Pharmaceutical Inc. 23
Clinical Trial Overview of Top Institutes / Government 24
Weill Cornell Medical College 24
Clinical Trial Overview of Weill Cornell Medical College 24
University of Rochester 25
Clinical Trial Overview of University of Rochester 25
New York Medical College 26
Clinical Trial Overview of New York Medical College 26
Masonic Cancer Center 27
Clinical Trial Overview of Masonic Cancer Center 27
Five Key Clinical Profiles 28
Appendix 62
Abbreviations 62
Definitions 62


Inquiry before buying this Report @ http://www.lifescienceindustryresearch.com/inquire-before-buying?rname=15876 . (Single User License : US$ 2500 And Corporate User License : US$ 7500)


For further information on “Batten Disease Global Clinical Trials Review, H1, 2014” report Contact sales@lifescienceindustryresearch.com / Call +1 888 391 5441.